Endovascular treatment of thromboangiitis obliterans (Buerger's disease)

MHS Modaghegh, S Hafezi - Vascular and Endovascular …, 2018 - journals.sagepub.com
Purpose: When critical limb ischemia (CLI) occurs in patients with thromboangiitis obliterans
(TAO) or Buerger's disease, smoking cessation alone may be insufficient to relieve rest pain …

[HTML][HTML] Molecular mechanisms regulating immune responses in thromboangiitis obliterans: A comprehensive review

A Shapouri-Moghaddam… - Iranian Journal of …, 2019 - ncbi.nlm.nih.gov
Thromboangiitis obliterans (TAO) is a thrombotic-occlusive as well as an inflammatory
peripheral vascular disease with unknown etiology. Recent evidence has supported the …

Long‐term outcome and prognostic factors of complications in thromboangiitis obliterans (Buerger's disease): a multicenter study of 224 patients

A Le Joncour, S Soudet, A Dupont… - Journal of the …, 2018 - Am Heart Assoc
Background Data regarding long‐term outcome of patients with thromboangiitis obliterans
are lacking and most series come from India and Japan. In this study, we assess long‐term …

A comprehensive review of the epidemiology and clinical features of 91 cases with Buerger's disease

MHS Modaghegh, MM Kamyar, A Shafiei… - …, 2023 - journals.sagepub.com
Background Thromboangiitis Obliterans (TAO) is a disease of small and medium-sized
arteries with an unclear natural course. This study aims to establish a national registry of the …

Did the clinical spectrum of thromboangiitis obliterans change in the past 40 years?

S Soudet, A Le Joncour, T Quemeneur… - …, 2020 - journals.sagepub.com
Thromboangiitis obliterans (TAO) is an inflammatory disease that usually affects small and
medium-sized arteries in the upper and lower limbs of young smokers. Previous studies …

Clinical outcomes of extended endovascular recanalization of 16 consecutive Buerger's disease patients

F Kacmaz, A Kaya, M Keskin, S Keceoglu, IH Algin… - …, 2019 - journals.sagepub.com
Objective Buerger's disease is one of the worst diseases causing peripheral artery
occlusions (especially lower extremity) with increased morbidity and mortality. Endovascular …

Effect of revascularization on IL-6 and TNF-α in patients with thromboangiitis obliterans

S Wu, X Sun, W Wu, D Shi… - Experimental and …, 2018 - spandidos-publications.com
The aim of the study was to investigate the effects of revascularization in treating patients
with thromboangiitis obliterans (TAO), to analyze the prognosis of TAO. The treatment group …

Humoral and cellular immune response to Buerger's disease

SM Ehteshamfar, JT Afshari, MHS Modaghegh… - …, 2020 - journals.sagepub.com
Objective Thromboangiitis obliterans is a nonatherosclerotic occlusive disease, affecting
small to moderate sized arteries of the upper and lower extremities, leading to progressive …

Senescent CD153+ T Lymphocytes Increase in the Peripheral Blood of Patients with Thromboangiitis Obliterans

N Mashhadi, L Kasraian, H Ghoddusi Johari… - Iranian Journal of …, 2023 - iji.sums.ac.ir
Background: Buerger's disease, also known as Thromboangiitis Obliterans (TAO), is a
progressive, inflammatory vascular disease with unknown etiology. Objective: To address …

Women and pregnancy in thromboangiitis obliterans

A Le Joncour, O Espitia, S Soudet, P Cacoub… - Journal of Vascular …, 2021 - karger.com
Data regarding women and thromboangiitis obliterans (TAO) are conflicted, and a few cases
of pregnancy have been described. We aimed to describe the interplay between TAO and …